FDA
approval
· 2019-06-03
FDA Approved: LEFLUNOMIDE — Original Application (KVK-Tech, Inc.)
Summary
FDA approves Leflunomide from KVK-Tech, Inc. via an Original Application (ANDA 212453). The product is indicated for rheumatoid arthritis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for LEFLUNOMIDE (LEFLUNOMIDE)